I. I am the Medical Director for the Inflammatory Bowel Disease (IBD) Program at Yale University. I treat patients in three locations - Temple Medical Building, Yale Health, and Yale-New Haven Hospital. The Inflammatory Bowel Disease Program is a multi-disciplinary program with medical, surgical, pediatric, pathology, and radiology specialists all participating in the care of our patients. Our program offers specialized nursing care and education with a nurse practitioner who specializes in patients with inflammatory bowel disease as well as an ostomy nurse who specializes in ostomy and wound care. Patients are self-referred as well as referred from other physicians. To schedule an appointment, please call 203-785-4138 (Temple Medical Building) or 203-432-0335 (Yale Health).
In addition to multi-disciplinary patient care, our program offers opportunities for patients to participate in research studies that evaluate mood disorders in IBD; treatment choices in IBD; and participation in multi-center new drug treatment protocols.
II. I am the gastroenterologist for the Hereditary Hemorrhagic Telangiectasia (HHT) Center at Yale . I evaluate and treat patients with HHT who have gastrointestinal bleeding and other gastrointestinal related problems. To schedule an appointment, please call Katharine Henderson at 203-737-5395.
III. International work -
1. I am the Site Director for the Yale/Stanford J&J Global Health Scholars Program's Cali, Colombia site. This program places our Yale residents at several international medical sites, including the Universidad del Valle in Cali, Columbia for international medical experiences.
2. I am on the Board of Directors for Honduras Children's Project, which is a non-profit organization dedicated to providing for the education of the children at Copprome Orphanage in El Progreso, Honduras.
- Crohn Disease
- Medical Oncology
Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians
Patient Care Organizations
Gastroenterology AB of Internal Medicine (1993)
|A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS|
|A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS|
|A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS|
|A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris suis Ova Treatment in Left-sided Ulcerative Colitis and its Effects on Mucosal Immune State and Microbiota|